












Dave Messina
Founder
Dr. Dave Messina has over 25 years of experience in healthcare and has been leading healthcare investments at Pioneer Fund since 2019. He has led 100+ deals including top portfolio companies like Gilgamesh ($1B exit to Abbvie) and Assort Health ($500M+ valuation). Previously he founded the RNA and machine learning company Cofactor Genomics (YC S15) and led it to national Medicare reimbursement. Dr. Messina also worked on the Human Genome Project.
Previously at

Thomas Jefferson School

Cofactor Genomics
Cofactor Genomics, LLC (Pharma Sequencing Services)

BioPerl Project

Stockholm University Student Union

Stockholm University

Cold Spring Harbor Laboratory

Washington University in St. Louis

Washington University School of Medicine in St. Louis

University of Chicago
Alumnus of
Stockholms universitet

Washington University School of Medicine in St. Louis
University of Illinois at Chicago